Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
PYXS
RNA
Add up to 3 more stocks
PYXS
Pyxis Oncology, Inc.
-9.82%
$2.02-0.22Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$127.98M
52W Range
$1.03 - $5.55
RNA
Atrium Therapeutics, Inc.
+0.25%
$7.99+0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$136.67M
52W Range
$7.63 - $16.77
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 11.19 | 0.64 |
| P/S Ratio | 11.59 | 5.82 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 82.8% | 97.9% |
| Operating Margin | -609.2% | -410.2% |
| Net Margin | -803.8% | -396.5% |
| ROE | -775.6% | -43.4% |
| ROA | -161.6% | -33.2% |
| ROIC | -314.7% | -38.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.34 | 8.73 |
| Quick Ratio | 1.34 | 8.73 |
| Debt/Equity | 1.56 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.